NCT02801708

Brief Summary

The aim of this study is to determine the diagnostic yield of continuous 7-day Holter ECG for detecting covert paroxysmal atrial fibrillation in patients with recent embolic stroke or transient ischemic attack (TIA) of undetermined cause after completion of a standard clinical work up including an initial 24-hour Holter monitoring.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 4, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 16, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

December 2, 2016

Status Verified

December 1, 2016

Enrollment Period

3.6 years

First QC Date

June 4, 2016

Last Update Submit

December 1, 2016

Conditions

Keywords

Embolic stroke of undetermined sourceAtrial fibrillation

Outcome Measures

Primary Outcomes (1)

  • Detection of any atrial fibrillation

    After examination of 7-day Holter monitoring (within 90 days of stroke onset)

Secondary Outcomes (5)

  • Change of antithrombotic drugs

    After the examination of 7-day Holter monitoring

  • Any ischemic or hemorrhagic event

    365 days after index stroke

  • Any adverse event related to 7-day Holter monitoring

    After the examination of 7-day Holter monitoring

  • Time to detection of atrial fibrillation on 7-day Holter monitoring

    After the examination of 7-day Holter monitoring

  • Atrial fibrillation burden

    After the examination of 7-day Holter monitoring

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with recent embolic stroke of undetermined source

You may qualify if:

  • Recent ESUS (within 3 months of onset) defined as:
  • A. Recent ischemic stroke (including transient ischemic attack with positive neuroimaging) visualized by brain imaging that is not lacunar B. Abscence of ≥ 50% stenosis or occlusion in cervical and intracranial arteries supplying ischemic area C. No atrial fibrillation after ≥ 24-hour Holter monitoring D. No intra-cardiac thrombus on transthoracic echocardiography E. No other major cardioembolic sources F. No other specific cause of stroke (for example, arteritis, dissection, migraine/vasospasm, drug abuse)
  • years of age or older
  • Signed written informed consent

You may not qualify if:

  • Previously documented atrial fibrillation
  • Untreated hyperthyroidism
  • Pacemaker or implantable cardioverter defibrillator implanted or planned to implant
  • Estimated life expectancy \< 12 months
  • Examination of seven-day Holter ECG not applicable within 3 months after stroke onset.
  • Patients considered inappropriate to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cerebral and Cardiovascular Center

Suita, Osaka, 565-8565, Japan

RECRUITING

Related Publications (1)

  • Miyazaki Y, Toyoda K, Iguchi Y, Hirano T, Metoki N, Tomoda M, Shiozawa M, Koge J, Okada Y, Terasawa Y, Kikuno M, Okano H, Hagii J, Nakajima M, Komatsu T, Yasaka M. Atrial Fibrillation After Ischemic Stroke Detected by Chest Strap-Style 7-Day Holter Monitoring and the Risk Predictors: EDUCATE-ESUS. J Atheroscler Thromb. 2021 May 1;28(5):544-554. doi: 10.5551/jat.58420. Epub 2020 Aug 15.

MeSH Terms

Conditions

StrokeAtrial Fibrillation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yuichi Miyazaki, MD

    National Cerebral and Cardiovascular Center, Japan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuichi Miyazaki, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 4, 2016

First Posted

June 16, 2016

Study Start

August 1, 2014

Primary Completion

March 1, 2018

Study Completion

March 1, 2019

Last Updated

December 2, 2016

Record last verified: 2016-12

Locations